Anthem Biosciences Ltd (ANTHEM) — Board Meeting | 8 September 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Settlement of upside sharing arrangement with principal shareholders approved by AGM.
🔄 What Changed
Finalized INR 1,276.83 million payment to Upside Principal Shareholders.
💡 Investor Takeaway
The settlement resolves the upside sharing obligation tied to the Viridity Tone LLP divestment.

Anthem Biosciences announced settlement of its upside sharing arrangement with principal shareholders following shareholder approval at the July 22, 2026 AGM, finalizing the INR 1,276.83 million payment related to the Viridity Tone LLP divestment, effective September 8, 2026.

📄 View Original Announcement (PDF)

About Anthem Biosciences Ltd (ANTHEM)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹53,084.93 Cr P/E: 91.9 ROE: 18.9% ROCE: 25.5% Div Yield: 0.21%

View full ANTHEM stock details →

📡 Get AI alerts when ANTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANTHEM — Free

📊 More ANTHEM filings

See all ANTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANTHEM files new disclosures

Track ANTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANTHEM — Free

Free account · 2 AI queries/day